Skip to main content

Roche Diagnostics to Spend $135M on Expansion in Indianapolis; 600 New Jobs Planned

NEW YORK, April 17 - Roche Diagnostics will invest more than $135 million in its Indianapolis facility as it embarks on a plan to expand R&D, laboratory, manufacturing, distribution, and information-technology operations.


The expansion, which is expected to create around 600 new jobs at the Indianapolis campus over the ensuing 10 years, is intended to support growth in the company's five diagnostics business areas: diabetes, central diagnostics, applied sciences, molecular diagnostics, and point of care.


In return for these "business improvements," Roche Diagnostics said it will receive over the next 10 years up to $22.2 million in local and state "economic-development incentives" in the form of state corporate income tax credits, training grants, property tax abatement savings, and public infrastructure improvements.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.